BMO Capital Reiterates Outperform Rating, $780 Price Target on Regeneron Pharma (REGN) Following Checkmate (CMPI) Acquisition Apr 19, 2022 08:48AM
Regeneron's (REGN) Acquisition of Checkmate (CMPI) Supports Thesis of "Uptick in M&A" in SMID-cap Biotechs - Truist Securities Apr 19, 2022 07:58AM